CME
Imatinib for Group 1 PAH
Host: Oksana A. Shlobin, MD
While there are now many effective drug treatments for PAH and PH, new molecular pathways of disease offer horizons for novel therapeutic developments that may, alone or in combination with existing, approved medicati